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Abstract
Introduction: Sinus histiocytosis with massive lymphadenopathy, also known as Rosai-Dorfman
Disease, is a rare and benign source of lymphadenopathy first described in 1969, which mimics
neoplastic processes. This disease commonly presents in children and young adults with supra-
diaphragmatic lymphadenopathy or extranodal lesions consisting of tissue infiltrates composed of
a polyclonal population of histiocytes. Since its description greater than 400 cases have been
described, sometimes in patients with a variety of treated and untreated neoplastic diseases.
However, the literature contains reports of only 19 cases of Rosai-Dorfman Disease in association
with lymphomas, Hodgkin's or non-Hodgkin's. The majority of these cases have the two diagnoses,
malignant lymphoma and Rosai-Dorfman Disease, separated in time. Interestingly,
infradiaphragmatic lymphadenopathy was a feature in the majority of previously reported cases of
Rosai-Dorfman Disease and non-Hodgkin's lymphoma.
Case presentation: This report provides details of a case with co-existing sinus histiocytosis with
massive lymphadenopathy and diffuse large B cell non-Hodgkin's lymphoma. This case is the fifth
described case of simultaneous Rosai-Dorfman Disease and concurrent non-Hodgkin's lymphoma.
Unfortunately, the diagnosis of a clinically aggressive diffuse large B cell lymphoma was made at
autopsy. The aggressive biological behavior of the diffuse large B cell lymphoma in this patient may
have been related to the underlying immune dysregulation believed to be part of the
pathophysiology of Rosai-Dorfman Disease.
Conclusion: Taken together this report and the preceding reports of Rosai-Dorfman Disease and
non-Hodgkin's lymphoma suggests that in cases with a diagnosis of Rosai-Dorfman Disease in the
setting of prominent infradiaphragmatic lymphadenopathy, clinicians should maintain a high index
of suspicion for the presence of occult non-Hodgkin's lymphoma especially if the clinical course is
atypical for classic Rosai-Dorfman Disease.
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Introduction
Sinus histiocytosis with massive lymphadenopathy
(SHML), also known as Rosai-Dorfman Disease (RDD), is
a rare entity first described in 1969 [1] that belongs to a
group of non-malignant histiocytic disorders in which
there is a pathologic increase in the number of histiocytes,
mainly mononuclear phagocytic cells and the antigen-
presenting cells of bone marrow origin [2], in nodal or
extra-nodal sites. This entity frequently mimics a malig-
nant neoplasm, however the clinical course can be varia-
ble ranging from spontaneous regression, to protracted
periods of stable lymphadenopathy, to the less frequent
observation of progressive lymphadenopathy [3]. Symp-
tomatic cases generally respond to mild or limited therapy
such as steroid treatment, although surgery, radiation
therapy and cytotoxic therapy have also been used [3]. The
etiology is still unknown although genetic, infectious, and
inflammatory etiologies have been postulated. This report
details a case of Rosai-Dorfman disease occurring concur-
rently with diffuse large B cell non-Hodgkin's lymphoma
and reviews the literature with respect to sinus histiocyto-
sis with massive lymphadenopathy/Rosai-Dorfman dis-
ease particularly with respect to the previously reported
cases of RDD with non-Hodgkin's lymphoma and the
association with infra-diaphragmatic or retroperitoneal
lymphadenopathy.
Case presentation
A 33 year-old Hispanic female patient with no significant
past medical history was seen in the outpatient clinic. She
presented with a three month history of increasing
abdominal discomfort, resulting in a sense of fullness,
decrease oral intake, lethargy and extensive weight loss of
15 Kilograms, a two month history of a dry nonproductive
cough, which was worse in the supine position, low grade
fevers without rigors, and mild night sweats that did not
reach the criteria for classic night sweats. At presentation
she was afebrile, mildly tachycardic (98–109 bpm), nor-
motensive and not distressed. Abdominal examination
revealed midline fullness slightly more prominent on the
left than the right side with some tenderness to palpation
in all four quadrants. Peripheral lymphadenopathy was
not appreciated by palpation and the remainder of the
physical examination was unremarkable. Laboratory data
revealed a normochromic microcytic anemia (hemo-
globin at 10.5 g/dl) and hypoalbuminemia (1.4 mg/dl)
with a normal liver enzyme panel. Electrolytes, white
blood cell count with differential & smear and coagula-
tion laboratories were all within institutional limits.
Imaging studies revealed the development of extensive,
primarily abdominal lymphadenopathy. An abdominal
ultrasound revealed extensive adenopathy in the periaor-
tic region, with a prominent hypoechoic mass at the left
renal pelvis and mild splenomegaly. A report of an
abdominal ultrasound performed five months earlier at a
separate facility was reported as being negative for patho-
logic findings. A CT scan of the chest, abdomen and pelvis
was performed revealed massive central lymphadenopa-
thy with no peripherally located lymphadenopathy. A
large lymphoid mass, 2.8 × 2.3 cm, was identified in the
azygoesophageal recess, Figure 1 Panel A, along with lim-
ited aortopulmonary and pretracheal lymph nodes all
measuring less than 1 cm in maximal dimension. In the
abdomen, there were multiple enlarged centrally necrotic
retroperitoneal lymph nodes, the largest conglomerate
was in the left periaortic area measuring 5.5 cm in maxi-
mal dimension, Figure 1 Panel B, and there was evidence
of significant bilateral common iliac lymphadenopathy,
Figure 1 Panel C. There was no evidence of pelvic sidewall
or inguinal lymphadenopathy. Also the patient was noted
to have mild hepatomegaly, splenomegaly of 13.4 cm,
mild right hydronephrosis and bilateral hydroureter.
The patient tested negative, by serology and culture, for
other causes of massive lymphadenopathy, which
included Coccidiomycosis, Aspergillus, Histoplasmosis, Blasto-
myces, Cryptococcus, Legionella and Tuberculosis. Serologic
markers for EBV (both IgG & IgM) and CMV were positive,
but did not support an acute infection by either agent.
Serologic screens for HIV and HSV type I, were negative.
Although the patient had elevated levels of C-reactive pro-
tein (>20+ mg/L) and serologic reactivity for anti-smooth
muscle antibodies, there were no anti-mitochondrial,
anti-nuclear, or anti-neutrophil cytoplasmic (both C & P)
antibodies detected. Serum AFP, CA-125 and CA 19-9 lev-
els were within normal limits.
The patient underwent an excisional biopsy of inferior ret-
roperitoneal lymph nodes by a laparoscopic procedure.
Three lymph nodes measuring 1.2 × 0.9 × 0.5 cm, 1 × 0.8
× 0.8 cm, and 0.9 × 0.9 × 0.7, respectively, were obtained
from this procedure. Flow cytometry was performed on
dispersed cells from the tissue sample and did not demon-
strate a monoclonal population of lymphocytes. Histo-
logic sections of the lymphatic tissue indicated increased
prominence of the sinuses with marked histiocytic prolif-
eration resulting in effacement of architecture containing
large histiocytes with vacuolated cytoplasm, Figure 2
Panel A. Some histiocytes contained lymphocytes in their
cytoplasm (emperipolesis), examples of which are high-
lighted by arrows, Figure 2 Panel B. The Immunohisto-
chemical staining revealed positive S-100 staining of
histiocytes, Figure 2 Panel C, and absent CD1a, CD15,
CD30 staining; features consistent with RDD. No evi-
dence of atypical or monoclonal lymphocytic prolifera-
tion was found.
The patient's hospital course followed an inexorable
decline with markedly decreased PO intake secondary toJournal of Medical Case Reports 2008, 2:70 http://www.jmedicalcasereports.com/content/2/1/70
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Computed Tomography at Presentation Figure 1
Computed Tomography at Presentation. Panel A. Chest CT demonstrating enlarged lymph node (LAD) in the azy-
goesophageal recess measuring 2.8 cm × 2.3 cm. Note the anterior deviation of the trachea. Az (azygous vein), Ao (aorta), Vb 
(vertebral body), SVC (superior vena cava). Panel B. Abdominal CT demonstrating multiple enlarged centrally necrotic retro-
peritoneal lymph nodes. The largest conglomerate, left periaortic lymph nodes, measured 5.5 cm × 5.0 cm. White arrows point 
to additional masses with central necrosis. Panel C, Abdominal CT demonstrating bilateral common iliac lymphadenopathy (C 
= common iliac artery).
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abdominal discomfort, persistent night sweating, fevers
and tachycardia. The patient required multiple erythro-
cyte transfusions with no evidence of hemolysis, overt
hemorrhage, or thrombocytopenia. A bone marrow
biopsy revealed a slightly hypercellular marrow with no
diagnostic abnormalities and cultures that remained neg-
ative. Post, excisional biopsy, the patient was cared for in
the intensive care unit (ICU) where parenteral nutrition
was started and respiratory support was provided, ulti-
mately requiring intubation and ventilator support. Treat-
ment with decadron at 40 mg IV daily was initiated after
pathologic evaluation of the excisional biopsy. This treat-
ment provided transient symptomatic improvement, but
the patient experienced increasing abdominal discomfort,
development of icteris (total bilirubin = 20.6, direct
bilirubin = 12, with an albumin of 1), and increasing pul-
monary infiltrates within a week. An extensive infectious
disease work-up including multiple cultures along with
bronchial alveolar levage (BAL) fluid cultures revealed
pathogenic organisms after more than a week in the ICU.
The identified organisms included, oral candidiasis, actin-
omycosis in blood, and on repeat BAL both 1+ HSV and
Photomicrographs of excisional lymph node biopsy Figure 2
Photomicrographs of excisional lymph node biopsy. Panel A, Lymph tissue demonstrating expanded sinuses with histi-
ocyte infiltration and distorted architecture. (HE stain, Original magnification 40 ×). Panel B. A higher magnification view dem-
onstrating lymphocytes inside histiocytes (HE stain, Original magnification 400 ×). Notice pale cytoplasm, ovoid nuclei with a 
single nucleolus and open chramatin of histiocytes in contrast to lymphocytes with smaller round nuclei and dense chromatin. 
Examples of emperipolesis are noted by arrows; grey arrows identify examples of single lymphocytes within histiocytes and a 
curvilinear group of five lymphocytes are bracketed by the black arrows. Panel C. This panel depicts immunohistochemical 
evaluation for S-100. The large histiocytes are immunoreactive to S100 with both cytoplasmic and nuclear staining and the 
unstained cells in the cytoplasm of histiocytes are engulfed lymphocytes (Immunohistochemical stain, Original magnification 
40×). Panel D. The panel contains a representative HE stained section from tissue obtained from the abdominal mass at 
autopsy depicting the diffuse large B cell non-Hodgkin's lymphoma diagnosed, the insert depicts positive anti-CD20 immunohis-
tochemical staining, (Original magnification 100 ×).Journal of Medical Case Reports 2008, 2:70 http://www.jmedicalcasereports.com/content/2/1/70
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1+ EBV. Despite broad-spectrum antibiotics, the patient
progressed to acute renal insufficiency, anasarca, and
refractory hypotension leading to death over several days.
At autopsy, the retroperitoneal & mediastinal lymphaden-
opathy had increased in size drammatically, encased vas-
cular structures and was contiguous with the pancreas
displacing the duodenum ventrally. Histologic examina-
tion showed extensive necrosis and regions of CD20 &
CD79a positive staining cells consistent with diffuse large
B cell lymphoma (DLBCL), Figure 2 Panel D. Markers for
T lymphocytes & histiocytes were negative within this
mass. The DLBCL also involved sections of thyroid. Pul-
monary actinomycosis or disseminated infectious proc-
esses were not demonstrated. Thus, the patient was
considered to have both DCBCL and RDD, although the
former predominated at autopsy.
Discussion
Sinus histiocytosis with massive lymphadenopathy
(SHML) or Rosai-Dorfman Disease (RDD) was first
described in 1969 [1], since then >400 cases have been
reported in the RDD registry [2,3]. This disease usually
affects individuals in childhood and early adulthood but
has a predilection for males of Caucasian and African
descent in their twenties [2,3]. It is generally considered a
benign histiocytic disorder. Other disorders in this group
include dendritic cell-related histiocytoses (like Langer-
hans cell histiocytosis), macrophage-related histiocytoses
(like hemophagocytic lymphohistiocytosis), and histiocy-
tosis from underlying malignancy or infection. However,
this entity has a unique histopathologic appearance that
distinguishes it from other processes in this group. RDD is
diagnosed on histologic or cytologic basis, when evidence
of abnormal amounts of histiocytes infiltrating lymph tis-
sue is observed [2,3]. The lymphoid tissue has massively
engorged sinuses and/or interfollicular areas with infil-
trating cells, which stain positive for S-100 protein [4,5].
Immunohistochemical staining studies clearly identify
RDD histiocytes as a separate process from T or B lym-
phoid population [4]. These cells are described as having
abundant pale cytoplasm, round-to-oval nuclei with a sin-
gle nucleolus and with evidence of lymphocytophagocy-
tosis or emperipolesis. The etiology of RDD is still
unknown. It has been noted to occur sporadically, with
occasional clustering, which suggests a genetic or an infec-
tious component [2]. It has been suggested that this dis-
ease is linked to a reactive disorder since it arises from
circulating mononuclear cells and there is an increase in
auto-immune antibodies in some affected individuals
[2,3]. Epstein-Bar virus and human herpes virus 6 has
been purposed as the infectious agent and recently other
diseases has been implicated like varicella zoster virus,
cytomegalovirus, Brucella, and Klebsiella [2]. It has also
been postulated that the development of RDD may be
driven by disregulated cytokine expression [2].
RDD commonly presents as bilateral painless cervical and
paratracheal lymphadenopathy, which can be massive, in
90 per cent of the cases [2]. Other less common sites of
involvement are inguinal, axillary, mediastinal and upper
paraaortic lymph nodes. Common sites of extranodal
involvement include skin, upper respiratory tract, Wal-
deyer's ring, and bone [2,3]. Rarely does this disease cause
systemic symptoms or organ dysfunction; the bone mar-
row, liver and spleen are usually spared. There are nonspe-
cific symptoms that may herald the onset of RDD such as
fevers and pharyngitis, which can be accompanied by
pain, tenderness, malaise, night sweats, weight loss and
anemia [2,3,5]. The course of this disease can remain
indolent for years and can spontaneously regress without
treatment and generally does not relapse. A few reported
cases became progressive and required treatment second-
ary to life threatening complications or organ dysfunc-
tion; prognosis is poor if there is involvement of kidneys,
lungs or wide spread nodal dissemination [5,6]. There is
no agreed upon treatment protocol. In most patients it is
acceptable to use a watch and wait approach. Progressive
or symptomatic disease is initially treated with a high dose
steroids followed by surgery, radiation and/or single agent
cytotoxic chemotherapy in refractory cases [5] with the
latter having relatively poor response rates. It is intriguing
that this patient had a transient improvement with the ini-
tiation of steroid therapy, possibly due to the effect on her
RDD and or the non-Hodgkin's lymphoma, however this
was short lived suggesting that the underlying debilita-
tion, immune compromise from both diagnoses, and the
aggressive growth characteristics of what proved to be an
unrecognized diffuse large B cell lymphoma led to her
demise.
This case report demonstrates a rare presentation of Rosai-
Dorfman disease (RDD) with Large B-Cell lymphoma. An
extensive search of the literature reveals only 19 reported
cases of lymphoma (Hodgkins and non-Hodgkins) occur-
ring in patients also diagnosed with RDD [7-16], Table 1.
There is temporal dissociation of these two diagnoses in
the majority of these cases with only 8 having concordant
presentation of both RDD and lymphoma although NHL
was diagnosed at the same time as RDD in four cases [7-
10] with most of the cases reporting that RDD and NHL
presented in separate nodal locations [9]. Interestingly,
prominant retroperitoneal lymphadenopathy has been a
frequent observation in these cases, as was seen in this
patient, rather than the typical supra-diaphragmatic lym-
phadenopathy [2] typically seen with RDD. Together, this
suggests that a diagnosis of RDD in the presence of mas-
sive retroperitoneal lymphadenopathy should be cause
for maintaining a high clinical index of suspicion for NHLJ
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Table 1: 
# Lymphoma histologic 
diagnosis
Lymphoma site(s) SHML/RDD site(s) Time Interval between Dx of 
SHML and initial lymphoma Dx
Additional Comments
1 Lu, et al (9) Follicular Center NHL Diffuse adenopathy & 
bone marrow
Left Inguinal lymph node Concurrent
2 Diffuse mixed small and large 
cell NHL
Extensive Mesenteric 
lymph nodes
Left inguinal lymph node SHML diagnosed 16 yr later 16 yr later concurrent follicular 
center NHL left inguinal lymph node
3 Lymphocyte predominant 
Hodgkins Disease
Left Axillary lymph 
nodes
Left Axillary lymph nodes Concurrent with HD see additional 
comment
14 yr later diffuse large B cell NHL – 
retroperitoneal lymph nodes
4 Shoda, et al (10) Diffuse large B cell NHL Bone marrow Cervical lymph nodes Concurrent
5 Garel, et al (7) Anaplastic Large Cell NHL Retroperitoneal, 
pelvic lymph nodes
Mediastinal Lymph nodes Concurrent
6 Focar, et al (3) Immunoblastic NHL CNS Central Nervous 
System
cervical and axillary lymph 
nodes
SHLM preceded NHL by 8 mo
7 NHL (NOS) Unknown Unknown Unknown
8 NHL (NOS) Unknown Unknown Unknown
9 Rangwala, et al 
(11)
Small non-cleaved (non-
Burkitt's) lymphoma
kidney & palate Inguinal lymph nodes SHLM preceded NHL by >4 yr
10 Krzemieniecki, et 
al (13)
High grade NHL (NOS) axillary lymph nodes cervical lymph nodes SHLM preceded NHL by 5 yr
11 Menzel, et al (14) High grade NHL (NOS) cervical lymph nodes Axillary & inguinal lymph 
nodes and SC tissues
SHML diagnosed 6 yr later
12 Kodura, et al (8) T cell NHL cervical lymph nodes Retroperitoneal lymph 
nodes
SHLM preceded NHL by 10 yrPublish with BioMed Central    and   every 
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and for consideration of additional biopsy of separate
nodal areas.
Conclusion
Simultaneous RDD and lymphoma remains a rare entity.
However, the diagnosis of RDD in the presence of promi-
nent subdiaphragmatic lymphadenopathy should raise
the index of suspicion for concomitant lymphoma espe-
cially in the setting of limited response to steroid therapy.
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